CAT No: CP01010
CAS No: 32926-43-5
Synonyms/Alias: Boc-His(Trt)-OH;32926-43-5;(S)-2-((tert-Butoxycarbonyl)amino)-3-(1-trityl-1H-imidazol-4-yl)propanoic acid;L-Histidine, N-[(1,1-dimethylethoxy)carbonyl]-1-(triphenylmethyl)-;(2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-(1-tritylimidazol-4-yl)propanoic acid;MFCD00153307;(2S)-2-{[(tert-butoxy)carbonyl]amino}-3-[1-(triphenylmethyl)-1H-imidazol-4-yl]propanoic acid;(S)-2-[(tert-Butoxycarbonyl)amino]-3-(1-trityl-1H-imidazol-4-yl)propanoic acid;C30H31N3O4;(2S)-2-[[(tert-Butoxy)carbonyl]amino]-3-[1-(triphenylmethyl)-1H-imidazol-4-yl]propanoic acid;N-[(1,1-Dimethylethoxy)carbonyl]-1-(triphenylmethyl)-L-histidine; (S)-2-[(tert-Butoxycarbonyl)amino]-3-(1-trityl-1H-imidazol-4-yl)propanoic Acid; Nalpha-Boc-N(im)-trityl-L-histidine;C9YH4KHR73;SCHEMBL9959535;OYXZPXVCRAAKCM-SANMLTNESA-N;Nalpha-Boc-N(im)-trityl-L-histidine;AKOS015903518;CS-W011504;DS-2286;FB42925;FD21670;HY-W010788;Boc-His(Trt)-OH, >=98.0% (TLC);DB-030155;Na-(tert-Butoxycarbonyl)-Nt-trityl-L-histidine;EN300-1589957;N-alpha-t-Butyloxycarbonyl-N-im-t-trityl-L-histidine;Boc-His(Trt)-OH, Nalpha-Boc-N(im)-trityl-L-histidine;N-[(1,1-Dimethylethoxy)carbonyl]-1-(triphenylmethyl)-L-histidine;(S)-2-(tert-butoxycarbonylamino)-3-(1-trityl-1H-imidazol-4-yl)propanoic acid;2-((TERT-BUTOXYCARBONYL)AMINO)-3-(1-TRITYL-1H-IMIDAZOL-4-YL)PROPANOIC ACID;685-644-6;
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C30H31N3O4 |
M.W/Mr. | 497.6 |
Sequence | Three Letter Code:Boc-His(1-Trt)-OH |
Abbr | His(Trt)-OH |
InChI | InChI=1S/C30H31N3O4/c1-29(2,3)37-28(36)32-26(27(34)35)19-25-20-33(21-31-25)30(22-13-7-4-8-14-22,23-15-9-5-10-16-23)24-17-11-6-12-18-24/h4-18,20-21,26H,19H2,1-3H3,(H,32,36)(H,34,35)/t26-/m0/s1 |
InChI Key | OYXZPXVCRAAKCM-SANMLTNESA-N |
Canonical SMILES | CC(C)(C)OC(=O)NC(CC1=CN(C=N1)C(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4)C(=O)O |
1. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
2. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
3. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
4. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.